Stay updated on Nivolumab for Oral Proliferative Verrucous Leukoplakia Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Oral Proliferative Verrucous Leukoplakia Clinical Trial page.

Latest updates to the Nivolumab for Oral Proliferative Verrucous Leukoplakia Clinical Trial page
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedRevision updated to v3.5.0. Previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.4.3 updated on the page, replacing the prior v3.4.2.SummaryDifference0.1%

- Check57 days agoChange DetectedAdded Revision: v3.4.2. Removed the notices about funding lapse and Revision: v3.4.1.SummaryDifference0.5%

- Check64 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center’s status was added, directing users to updated information. The site version was updated from Revision: v3.4.0 to Revision: v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange DetectedAdded a glossary toggle, Last Update Submitted that Met QC Criteria label, No FEAR Act Data label, and Revision: v3.4.0. Removed: Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

- Check85 days agoChange DetectedFooter shows Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.1%

Stay in the know with updates to Nivolumab for Oral Proliferative Verrucous Leukoplakia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Oral Proliferative Verrucous Leukoplakia Clinical Trial page.